Plexium Picks Up $28M For Cancer, Neurogenerative Disease Efforts
socalTECH
OCTOBER 17, 2019
San Diego-based Plexium , which is developing E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases, has raised $28 in a Series A funding round, the company announced on Thursday morning. The funding was led by DCVC Bio and The Column Group, and also included M Ventures, CRV, and Neotribe Ventures.
Let's personalize your content